Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
MOXODENE, MOXONIDINE GPPL, MOXONIDINE GENPAR, MOXOTENS (Generic Partners Pty Ltd)
Product name
MOXODENE, MOXONIDINE GPPL, MOXONIDINE GENPAR, MOXOTENS
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
244 working days (255)
Active ingredients
moxonidine
Registration type
New generic medicine
Indication
MOXODENE, MOXONIDINE GPPL, MOXONIDINE GENPAR, MOXOTENS (tablets) are indicated for the treatment of hypertension.